Only 10 innovative pharmaceutical companies spent over 10% on R&D

Published: 2016-07-21 12:05:00

Updated: 2016-07-21 12:05:00

It was surveyed there were only less than 10 companies which exceeded 10% in the R&D expense rate against sales among innovative pharmaceutical companies.

Moreover, it was observed there were the total 4 innovative pharmaceutical companies which spent more than KRW 100 billion annual investments into R&D, such as Celltrion and Hanmi Pharm.

The Ministry of Health and Welfare has selected the...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.